Our company is prioritising deeper collaborations with CDMOs and biosimilar companies as part of its strategy to expand its footprint across India, Middle East, and Africa region
The collaboration will roll out an “agentic” AI platform across Merck’s research & development, manufacturing, commercial, and corporate operations
Neuland Laboratories reported an uptick in peptide-related engagements from Japanese companies, particularly at the preclinical and early clinical stages
Together, the companies aim to deliver an integrated toolkit for biomarker discovery and clinical research
The collaboration underscores a broader industry shift toward hybrid research models that integrate computational biology with advanced experimental systems
The newly approved pill combines 100 mg of doravirine with 0.25 mg of islatravir
The newly formed team is led by Tomabu Adjobimey, an immunologist known for his work in host-pathogen interactions and immune modulation
Shift from approvals to digital intimation via NSWS portal aims to cut timelines and boost innovation in early-stage drug development
Narasimhan’s appointment underscores the growing importance of AI in transforming drug discovery
Dr Shivkumar Kalyanaraman emphasizes need for quality research, partnerships, and measurable outcomes
Subscribe To Our Newsletter & Stay Updated
